Clinical trial of L-Carnitine and valproic acid in spinal muscular atrophy type I.

Address: Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Department of Physical Therapy, Institute of Health Professions, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, Simches 5-240, Boston, Massachusetts, 02114, USA.; Department of Neurology, University of Utah, Salt Lake City, Utah, USA.; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.; Connecticut Children's Medical Center, Hartford, Connecticut, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Department of Pediatrics, Hospital of the University of Cologne, Cologne, Germany.; Department of Pediatrics, Saint-Justine Hospital, Montreal, Quebec, Canada.; Biochemistry and Medical Genetics, University of Manitoba, Winnepeg, Manitoba, Canada.; Department of Molecular Pathology, The Ohio State University, Columbus, Ohio, USA.; CBS Squared, Inc, Fort Washington, Pennsylvania, USA.; Department of Bioinformatics, University of Utah, Salt Lake City, Utah, USA.; Department of Neurology, State University of New York, Syracuse, New York.; Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases Cologne.; Institute of Genetics, University of Cologne, Cologne, Germany.